Natural health product · NPN 80038212
MaxOne
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed December 11, 2012; licence last revised April 12, 2019.
- Natural Product Number (NPN)
- 80038212
- Licence holder
- Max International LLC
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- December 11, 2012
- Licence last revised
- April 12, 2019
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| D-Ribose-L-cysteine | 125 mg | 60 mg L-Cysteine |
| D-Ribose-L-cysteine | — | 74 mg Ribose |
| D-Ribose-L-cysteine | — | 44.7 % L-Cysteine |
| D-Ribose-L-cysteine | — | 55.3 % Ribose |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- To support the natural production of glutathione by providing the amino acid, cysteine. D-Ribose-L-Cysteine supports the natural production of glutathione by providing the precursor amino acid, L-Cysteine for the maintenance of good health. Increases the levels of the antioxidant, glutathione for the maintenance of good health. Promotes the production of glutathione, an important antioxidant in the body. Helps to promote improved oxidative status and is a source of cysteine for the maintenance of good health. A source of cysteine, a precursor of glutathione an antioxidant for the maintenance of good health.
Non-medicinal ingredients
Microcrystalline cellulose; Stearic Acid; Titanium dioxide; Hypromellose; Silicon dioxide